Minimal Component, Protein-Free, and Cost-effective Human Pluripotent Stem Cell Cardiomyocyte Differentiation

Area of Science:

• Stem Cell Biology
• Cardiovascular Research
• Regenerative Medicine

Background:

• Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) are vital for in vitro cardiac disease modeling, cardiotoxicity screening, and regenerative therapies.
• Existing hPSC-CM differentiation protocols are often complex, expensive, and utilize animal-derived components, limiting their application in regenerative medicine.
• There is a need for efficient, cost-effective, and scalable methods for generating hPSC-CMs suitable for clinical applications.

Purpose of the Study:

• To develop an efficient, cost-effective, and protein-free protocol for differentiating human pluripotent stem cells into cardiomyocytes.
• To simplify the hPSC-CM differentiation process by minimizing expensive and xenobiotic components.
• To enhance the utility of hPSC-CMs for various applications, including drug discovery and cell therapies.

Main Methods:

• Developed a two-component differentiation protocol using DMEM/F12 basal medium and l-ascorbic acid 2-phosphate.
• Eliminated the need for expensive supplements like B27 medium and animal-derived growth factors.
• Included basic protocols for hPSC culture, hPSC-CM differentiation, and characterization via immunofluorescence imaging.

Main Results:

• The new protocol is efficient, cost-effective, and protein-free, significantly reducing complexity and cost.
• Eliminating xenobiotic and complex components increased differentiation efficiency and decreased variability.
• The protocol enhances the scalability of hPSC-CM production.

Conclusions:

• This simplified, low-cost cardiac differentiation protocol improves the utility and applicability of hPSC-CMs.
• The method supports broader use of hPSC-CMs in drug discovery, cell therapies, tissue engineering, disease modeling, and precision medicine.
• Adaptation of this protocol will advance cardiac regenerative medicine.